These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34059426)

  • 1. Adherence to Pre-Exposure Prophylaxis in Adolescents and Young Adults: A Systematic Review and Meta-Analysis.
    Allison BA; Widman L; Stewart JL; Evans R; Perry M
    J Adolesc Health; 2022 Jan; 70(1):28-41. PubMed ID: 34059426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis.
    Wood S; Dowshen N; Bauermeister JA; Lalley-Chareczko L; Franklin J; Petsis D; Swyryn M; Barnett K; Weissman GE; Koenig HC; Gross R
    J Adolesc Health; 2020 Mar; 66(3):268-274. PubMed ID: 31672523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated with Retention and Adherence in a Comprehensive, Diverse HIV Pre-Exposure Prophylaxis Clinic.
    Goodman A; Patten L; Castillo-Mancilla J; Zimmer S; Madinger N; Frasca K
    AIDS Res Hum Retroviruses; 2022 Apr; 38(4):327-335. PubMed ID: 34861765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure Prophylaxis Uptake, Adherence, and Persistence: A Narrative Review of Interventions in the U.S.
    Garrison LE; Haberer JE
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S73-S86. PubMed ID: 34686294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Condomless Anal Sex Associated With Heterogeneous Profiles Of HIV Pre-Exposure Prophylaxis Use and Sexual Activities Among Men Who Have Sex With Men: A Latent Class Analysis Using Sex Diary Data on a Mobile App.
    Yu YF; Wu HJ; Ku SW; Huang PH; Li CW; Huang P; Strong C
    J Med Internet Res; 2021 Dec; 23(12):e33877. PubMed ID: 34941560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-synthesis of Qualitative Research of Pre-exposure Prophylaxis (PrEP) Adherence Among Men Who Have Sex With Men (MSM).
    Ching SZ; Wong LP; Said MAB; Lim SH
    AIDS Educ Prev; 2020 Oct; 32(5):416-431. PubMed ID: 33112675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis.
    Zhang J; Li C; Xu J; Hu Z; Rutstein SE; Tucker JD; Ong JJ; Jiang Y; Geng W; Wright ST; Cohen MS; Shang H; Tang W
    Lancet HIV; 2022 Apr; 9(4):e254-e268. PubMed ID: 35364026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute HIV Diagnosis After Initiation of Pre-exposure Prophylaxis in a Young Adult Patient: A Case Report.
    Warus J; Hidalgo MA; Belzer M; Olson-Kennedy J
    J Adolesc Health; 2024 Jan; 74(1):205-207. PubMed ID: 37690011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.
    Yi S; Tuot S; Mwai GW; Ngin C; Chhim K; Pal K; Igbinedion E; Holland P; Choub SC; Mburu G
    J Int AIDS Soc; 2017 Jun; 20(1):21580. PubMed ID: 28691439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Pre-Exposure Prophylaxis Medication for Adolescents and Young Adults: A Position Paper of the Society for Adolescent Health and Medicine.
    Society for Adolescent Health and Medicine
    J Adolesc Health; 2018 Oct; 63(4):513-516. PubMed ID: 30286903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
    Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
    Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China.
    Hu Y; Zhong XN; Peng B; Zhang Y; Liang H; Dai JH; Zhang JY; Huang AL
    BMC Infect Dis; 2018 Nov; 18(1):575. PubMed ID: 30442106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent Health Providers' Willingness to Prescribe Pre-Exposure Prophylaxis (PrEP) to Youth at Risk of HIV Infection in the United States.
    Hart-Cooper GD; Allen I; Irwin CE; Scott H
    J Adolesc Health; 2018 Aug; 63(2):242-244. PubMed ID: 29843969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experienced barriers to adherence to pre-exposure prophylaxis for HIV prevention among MSM: a systematic review and meta-ethnography of qualitative studies.
    Edeza A; Karina Santamaria E; Valente PK; Gomez A; Ogunbajo A; Biello K
    AIDS Care; 2021 Jun; 33(6):697-705. PubMed ID: 32530302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM).
    Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B
    AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.